Ngenla
Payments companies reported to CMS as associated with Ngenla. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ngenla, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ngenla
These are the largest totals companies reported as associated with Ngenla. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lawrence Silverman | Morristown, NJ | Pediatric Endocrinology | $89,700.43 |
| Aristides Maniatis | Centennial, CO | Pediatric Endocrinology | $85,043.17 |
| Paul Saenger | Mineola, NY | Pediatric Endocrinology | $19,289.86 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $15,554.09 |
| Andrew Dauber | Cincinnati, OH | Pediatric Endocrinology | $13,632.50 |
| Craig Alter | Philadelphia, PA | Pediatric Endocrinology | $8,844.18 |
| Robert Rapaport | New York, NY | Pediatric Endocrinology | $8,529.01 |
| Teresa Quattrin | Buffalo, NY | $8,441.75 | |
| Mitchell Geffner | Los Angeles, CA | Pediatric Endocrinology | $6,443.37 |
| Amrit Bhangoo | Long Beach, CA | Pediatric Endocrinology | $6,034.99 |
Prescribed Ngenla?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.